REFERENCES
- Lundegardh G, Adami HD, Malker B. Gastric cancer survival in Sweden. Lack of improvement in 19 years. Ann Surg 1986; 204: 546–51.
- Preusser P, Achterath W, Wilke H, et al. Chemotherapy of gastric cancer. Cancer Treat Rev 1988; 15: 257–77.
- Wilke H, Preusser P, Fink U. Etoposide (E)/ leucovorin (L)/ 5-fluorouracil (F), (ELF) in advanced gastric cancer. A phase I/II trial (abstract), in Proceedings of the NCI-EORTC symposium on new drugs in cancer therapy, Amsterdam 1989.
- Wilke H, Preusser P, Fink U, et al. High dose folinic acid/etoposide/5-fluorouracil in advanced gastric cancer - A phase II study in elderly patients with cardiac risk. Invest New Drugs 1990; 8: 65–70.
- Williams A. EuroQol - a new facility for the measure-ment of health related quality of life. The EuroQol group. Health Policy 1990; 16: 199–208.
- Lise M, Nitti D, Buyse M, Cartel G, Fornasiero A, Guimmares Dos Santos J. Phase III clinical trial of adjuvant FAM2 (5-FU, Adriamycin and mitomycin C) vs control in resectable gastric cancer. A study of the EORTC Gastrointestinal Tract Cancer Cooperative Group. Cancer Res 1988; 110: 36–43.
- Coombs RC, Schein PS, Chilvers CPD, Wils J, Beretta G, Bliss JM. A randomized trial comparing adjuvant fluo-rouracil, doxorubicin and mitomycin with no treatment in operable gastric cancer. J Clin Oncol 1990; 8: 1362–9.
- Wils J, Bleiberg H, Blijham G, Mulder N, Planting A, Splinter T. An EORTC gastrointestinal evaluation of the com-bination of sequential methotrexate (MTX) and 5-fluorouracil (F) combined with adriamycin (A) (FAMTX) in advanced measurable gastric cancer. J Clin Oncol 1986; 4: 1799-803.
- Wils JA, Klein HD, Wagener DJTH, Bleiberg H, Reis H, Doraten F. Sequential high-dose methotrexate and fluo-rouracil combined with doxorubicin, a step ahead in the treatment of advanced gastric cancer. A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group. Clin Oncol 1991; 5: 827–31.
- Alexander RH, Kelsen DP, Tepper JE. Cancer of the stomach, In DeVita VT, HellmanS, Rosenberg SA (red). Cancer principles & practice of oncology. Philadelphia, Lippincott Company 1993;818-48.
- Epstein RJ. Does the breast cancer dollar make sense? Eur J Cancer 1992; 28: 486–91.